02/12/2025
Dr. Joshua Moss, oncology resident at the Sharett Oncology Institute and principal investigator at the Hadassah Cancer Research Institute (HCRI), has been awarded a prestigious research grant at the ISHNOS Annual Conference.
His study—conducted with Prof. Aron Popovtzer, Director of the Sharett Oncology Institute and HCRI—aims to develop an innovative, personalized method for monitoring radiotherapy in head and neck cancer patients using circulating cell-free DNA.
We’re also proud to celebrate Dr. Shay Sharon, DMD, MD, PhD, specialist in Oral and Maxillofacial Surgery at Hadassah, who received the Inspiring Lecture Award for his groundbreaking work on the intra-tumoral microbiome in oral cavity squamous cell carcinoma.
This cutting-edge research is shaping the future of personalized cancer care—right here at Hadassah.
Congratulations to Dr. Moss, Dr. Sharon, and the entire Hadassah research family!